KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Round 8 of Biomedical Catalyst awards announced

Twelve new treatments, diagnostics and medical technologies will receive funding from the eighth round of the successful Biomedical Catalyst (BMC), a joint programme run by the MRC, which contributed £13m of the total £18m in this round, and Innovate UK.

The BMC supports UK academics and small to medium-sized businesses seeking to take their research from discovery through to commercialisation to deliver patient benefit. Any UK small or medium-sized business or academic institution undertaking research and development has been able to apply to the BMC on a rolling basis, with applications assessed by independent experts.

This latest round brings the total number of BMC awards to 318 since 2011, when it was set up, with a total investment of more than £370 million split between the MRC, Innovate UK and leveraged funding from industry.

MRC-funded awards in this round ranged from development of a targeted therapy for inflammatory bowel disease to pre-clinical development of a universal flu vaccine. 

The MRC’s Chief Executive, Professor Sir John Savill, said: “This round of awards is a further demonstration of the exceptional science coming out of the vibrant academic and industrial research base of the UK.  The continued success of the MRC/IUK Biomedical Catalyst illustrates the value of dedicated support to ensure that this country can rapidly exploit world-leading science for the benefit of patients and the UK economy."

Minister for Life Sciences George Freeman, said: “The UK’s healthcare industry has a worldwide reputation for excellence.  By providing early support to these latest treatment and diagnosis developments, we are not only going to potentially help improve or save lives, we are helping businesses grow and boost the UK’s productivity.”

Chief Executive of Innovate UK, Dr Ruth McKernan said: “Delivering efficient and effective healthcare has never been more important, and innovation is central to making that happen. Through the Biomedical Catalyst, we have backed innovative companies that are taking on this challenge and developing the medical advances of the future that will potentially help to save lives and money.”

More details on the announcment here